August 25, 2015 | Navidea Biopharmaceuticals announced that it would register its shares in a dual listing on the Tel Aviv Stock Exchange (TASE). The biopharmaceutical company that produces precision diagnostics, therapeutics and radiopharmaceutical agents is already listed on the New York Stock Exchange. Dual listing on the TASE is allowed in the United States and Israel without any additional regulatory requirements. Navidea Biopharmaceuticals is headquartered in Ohio.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

UN Honors Israeli Food Exec For Sustainability Work
September 26, 2023

Startup Unveils Tech To Speed Up Growth Of Cultivated Meat
September 26, 2023

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Facebook comments